Now showing items 1-3 of 3

    • Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer 

      Vilaprinyo Terré, Ester; Forné Izquierdo, Carles; Carles Lavila, Misericordia; Sala i Serra, Maria; Pla Farnós, Roger; Castells, Xavier; Domingo, Laia; Rué i Monné, Montserrat; Interval Cancer Study Group (Public Library of Science, 2014)
      The one-size-fits-all paradigm in organized screening of breast cancer is shifting towards a personalized approach. The present study has two objectives: 1) To perform an economic evaluation and to assess the harm-benefit ...
    • Impact of risk factors on different interval cancer subtypes in a population-based breast cancer screening programme 

      Blanch, Jordi; Sala i Serra, Maria; Ibáñez, Josefa; Domingo, Laia; Fernández, Belén; Otegi, Arantza; Barata, Teresa; Zubizarreta, Raquel; Ferrer, Joana; Castells, Xavier; Rué i Monné, Montserrat; Salas, Dolores; Interval Cancer Study Group (Public Library of Science, 2014-10-21)
      Background: Interval cancers are primary breast cancers diagnosed in women after a negative screening test and before the next screening invitation. Our aim was to evaluate risk factors for interval cancer and their subtypes ...
    • Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in Spain 

      Domingo, Laia; Salas, Dolores; Zubizarreta, Raquel; Baré, Marisa; Sarriugarte, Garbiñe; Barata, Teresa; Ibáñez, Josefa; Blanch, Jordi; Puig-Vives, Montserrat; Fernández, Ana Belén; Castells, Xavier; Sala i Serra, Maria; Interval Cancer Study Group (BioMed Central, 2014)
      Introduction: Interval cancers are tumors arising after a negative screening episode and before the next screening invitation. They can be classified into true interval cancers, false-negatives, minimal-sign cancers, and ...